Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
Oncogene
|
July 30, 2020
Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing
Yuchen Wang, Yanna Liu, Wenfeng Deng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN task force: clinical utility of PET in a variety of tumor types
Donald A Podoloff, Douglas W Ball, Edgar Ben-Josef, et al.
Oncotarget
|
October 10, 2014
The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells
Lymor Ringer, Paul Sirajuddin, Lucas Tricoli, et al.
JAMA Oncology
|
September 1, 2022
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial
Nizar M Tannir, Neeraj Agarwal, Camillo Porta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
Science (New York, N.Y.)
|
September 19, 2015
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T Miyamoto, Yu Zheng, Ben S Wittner, et al.
Science Translational Medicine
|
April 29, 2010
Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer
Shannon L Stott, Richard J Lee, Sunitha Nagrath, et al.
Cell
|
June 16, 2023
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
Hongshan Guo, Joanna A Vuille, Ben S Wittner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
Sophia C Kamran, Yuzhen Zhou, Keisuke Otani, et al.
Nature Communications
|
February 10, 2017
Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination
Yu Zheng, David T Miyamoto, Ben S Wittner, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
Oncogene
|
July 30, 2020
Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing
Yuchen Wang, Yanna Liu, Wenfeng Deng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN task force: clinical utility of PET in a variety of tumor types
Donald A Podoloff, Douglas W Ball, Edgar Ben-Josef, et al.
Oncotarget
|
October 10, 2014
The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells
Lymor Ringer, Paul Sirajuddin, Lucas Tricoli, et al.
JAMA Oncology
|
September 1, 2022
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial
Nizar M Tannir, Neeraj Agarwal, Camillo Porta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
Science (New York, N.Y.)
|
September 19, 2015
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T Miyamoto, Yu Zheng, Ben S Wittner, et al.
Science Translational Medicine
|
April 29, 2010
Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer
Shannon L Stott, Richard J Lee, Sunitha Nagrath, et al.
Cell
|
June 16, 2023
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
Hongshan Guo, Joanna A Vuille, Ben S Wittner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
Sophia C Kamran, Yuzhen Zhou, Keisuke Otani, et al.
Nature Communications
|
February 10, 2017
Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination
Yu Zheng, David T Miyamoto, Ben S Wittner, et al.
Page
of 10